Publications by authors named "Rahul D Shingare"

Article Synopsis
  • The rise in tuberculosis cases has increased the need for new treatment options, prompting research into novel anti-TB compounds.
  • Researchers developed silicon-based analogues of a compound called BM212, which targets the mycolic acid transporter MmpL3 in Mycobacterium tuberculosis, and found them to be more effective than the original compound.
  • Among these compounds, one (compound 12) demonstrated remarkable potency with a MIC of 0.1 μM, showing promise for further development as an anti-tubercular agent due to its favorable drug properties.
View Article and Find Full Text PDF

The complex heterogenic environment of tumour mass often leads to drug resistance and facilitate chemo insensitivity triggering more malignant phenotypes among cancer patients. Major DNA-damaging cancer drugs have been consistently proven unsuccessful in terms of elevating chemo-resistance. (±)-peharmaline A, a hybrid natural product isolated from seeds of Peganum harmala L.

View Article and Find Full Text PDF

We report the first total synthesis of an antimycobacterial natural product oxazinin A that takes advantage of a multi-component cascade reaction of anthranilic acid and a precursor polyketide containing an aldehyde. The route utilized for the synthesis of the pseudodimeric oxazinin A validates a previously proposed biosynthetic mechanism, invoking a non-enzymatic pathway to the complex molecule. We found a 76 : 10 : 9 : 5 ratio of oxazinin diastereomers from the synthetic cascade, which is an identical match to that found in the fermentation media from the fungus Eurotiomycetes 110162.

View Article and Find Full Text PDF
Article Synopsis
  • - Research focused on creating new compounds based on the antibiotic natural product hunanamycin A, followed by testing their biological effectiveness.
  • - A promising compound, identified as compound 36, showed strong activity against Salmonella enterica and had favorable drug-like properties.
  • - Testing in Swiss albino mice indicated that compound 36 was not acutely toxic at doses up to 2 g/kg, suggesting its potential for treating foodborne infections caused by Salmonella.
View Article and Find Full Text PDF

Biofilms, the predominant growth mode of microorganisms, pose a significant risk to human health. The protective biofilm matrix, typically composed of exopolysaccharides, proteins, nucleic acids, and lipids, combined with biofilm-grown bacteria's heterogenous physiology, leads to enhanced fitness and tolerance to traditional methods for treatment. There is a need to identify biofilm inhibitors using diverse approaches and targeting different stages of biofilm formation.

View Article and Find Full Text PDF

Pyonitrins A-D are recently isolated natural products from the insect-associated strain, which were isolated from complex fractions that exhibited antifungal activity via an murine candidiasis assay. Genomic studies of suggested that pyonitrins A-D are formed via a spontaneous nonenzymatic reaction between biosynthetic intermediates of two well-known natural products pyochelin and pyrrolnitrin. Herein we have accomplished the first biomimetic total synthesis of pyonitrins A-D in three steps and studied the nonenzymatic formation of the pyonitrins using N NMR spectroscopy.

View Article and Find Full Text PDF

A simple and practical method to access a variety of benzimidazol-2-ones is reported here. A series of -alkyl-substituted benzimidazol-2-ones were synthesized by decarbonylative ring contraction starting from corresponding quinoxalinediones for the first time. The utility of the method has been demonstrated by synthesizing recently approved controversial drug flibanserin (Addyi) and a urea analogue of marine antibiotic natural product hunanamycin-A.

View Article and Find Full Text PDF

The structural similarity between an MmpL3 inhibitor BM212, and a cannabinoid receptor modulator rimonabant, prompted us to investigate the anti-tubercular activity of rimonabant and its analogues. Further optimization, particularly through incorporation of silicon into the scaffold, resulted in new compounds with significant improvement in anti-tubercular activity against Mycobacterium tuberculosis (H37Rv). The sila analogue 18a was found to be the most potent antimycobacterial compound (MIC, 31 ng/mL) from this series with an excellent selectivity index.

View Article and Find Full Text PDF

The first total synthesis of hunanamycin A, an antibiotic natural product with a pyrido[1,2,3-de]quinoxaline-2,3-dione core from a marine-derived Bacillus hunanensis, is disclosed. The present effort provides access to sufficient amounts of scarce hunanamycin A for further biological evaluation and confirmation of the assigned absolute configuration. In addition, four new analogues of the natural product are reported.

View Article and Find Full Text PDF